Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Corona Remedies Ltd has submitted its Annual Secretarial Compliance Report for FY 2025-26, certified by Practicing Company Secretary Dhara Patel. The report confirms full compliance with all applicable SEBI regulations including LODR, ICDR, SAST, PIT, and Depositories regulations. All 12 compliance areas examined received a 'Yes' status, including secretarial standards, board processes, related party transactions, insider trading norms, and website disclosures. No deviations, violations, or fines were reported. No actions were taken by SEBI or stock exchanges against the company, its promoters, or directors during the review period.
This is a clean compliance report indicating strong corporate governance practices. Shareholders can take comfort that the company maintained proper statutory compliances and board processes throughout FY 2025-26 with no regulatory concerns raised by authorities.